Hegi, Monika E; Stupp, Roger (2015). Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter - still a dilemma? Neuro-Oncology, 17(11):1425-1427.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
Additional indexing
Item Type: | Journal Article, refereed, original work |
---|---|
Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology and Hematology |
Dewey Decimal Classification: | 610 Medicine & health |
Scopus Subject Areas: | Health Sciences > Oncology
Health Sciences > Neurology (clinical) Life Sciences > Cancer Research |
Language: | English |
Date: | November 2015 |
Deposited On: | 04 Feb 2016 09:31 |
Last Modified: | 26 Jan 2022 08:25 |
Publisher: | Oxford University Press |
ISSN: | 1522-8517 |
OA Status: | Hybrid |
Free access at: | PubMed ID. An embargo period may apply. |
Publisher DOI: | https://doi.org/10.1093/neuonc/nov198 |
PubMed ID: | 26374690 |
Users (please log in): Suggest update or correction for this item
For submitters/editors: Edit metadata
Permanent URL: https://doi.org/10.5167/uzh-120124
Download
- Content: Published Version
- Language: English
- Description: Nationallizenz 142-005
- Content: Published Version
- Language: English
- Description: Nationallizenz 142-005
Links
Authors, Affiliations, Collaborations

Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
UniversitatsSpital Zurich, Zurich, Switzerland